Clinical effect of Aricept combined with Mecobalamin in the treatment of vascular dementia
LIU Na1 LI Xue-fei2
1. Department of Neurology,the First People′s Hospital of Zhenjiang City in Jiangsu Province,Zhenjiang 212000,China;
2. Department of Ultrasound,Central Hospital of Tai′an City in Shandong Province,Tai′an 271000,China
Abstract:Objective To investigate the effect of Aricept combined with Mecobalamin in the treatment of vascular dementia. Methods A total of 80 patients of vascular dementia admitted to the First People′s Hospital of Zhenjiang City from January to December in 2018 were selected and divided into the combinated group (40 cases) and the control group (40 cases) according to the randomized control method. Patients in the combinated group were given Aricept combined with Mecobalamin,while patients in the control group were only given Aricept. The cognitive ability of the two groups before and after treatment was compared,evaluated by mini mental state examination (MMSE) and Montreal Cognitive Assessment (MoCA),at the same time,the adverse reactions of the two groups were observed. Results There were no significant differences in the MMSE,MoCA scores between the two groups before treatment (P>0.05). The MMSE,MoCA scores of the two groups after treatment were higher than those before treatment,the difference were statistically significant (P<0.05). The MMSE,MoCA scores of the combined group were higher than those of the control group,the difference were statistically significant (P<0.05). Compared with the control group,there was no significant increase in adverse reactions in the combined group,without significant difference (P>0.05). Conclusion Aricept combined with Mecobalamin can improve the cognitive function and daily living ability of vascular dementia patients,the clinical effect is accurate and safe,which is better than that of Aricept alone.
刘娜; 李雪飞. 多奈哌齐联合甲钴胺治疗血管性痴呆的临床效果[J]. 中国当代医药, 2020, 27(18): 56-58转62.
LIU Na; LI Xue-fei. Clinical effect of Aricept combined with Mecobalamin in the treatment of vascular dementia. 中国当代医药, 2020, 27(18): 56-58转62.
Qi L,Siyu H,Yao C.Donepezil -based multi -functional cholinesterase inhibitors for treatment of Alzheimer′s disease[J].Eur J Med Chem,2018,158(3):463-477.
[9]
Oksana G,Kowy H,Cheng XL,et al.A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies[J].Chem Biol Interact,2019,309:108 698.
[10]
Briggs R,Kennelly SP,O′Neill D.Drug treatments in Alzheimer′s disease[J].Clin Med,2016,16(5):247-253.
Ren XJ,Zhang Y,Zhang F,et al.Red-emitting fluorescent probe for discrimination of Cys/Hcy and GSH with a large stokes shift under a single- wavelength excitation[J].Analytica Chimica Acta,2019,11(9):166-172.
[13]
Sonoda M,Shoj T,Kuwamural Y,et al.Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus[J].Sci Rep,2017,7(1):4382-4385.
Ridgway ND.The role of phosphatidylcholine and choline metabolites to cell proliferation and survival[J].Crit Rev Biochem Mol Biol,2013,48(9):20-38.
[16]
Mishra VA,Harbada R,Sharma A.Vitamin B12 and vitamin D deficiencies:an unusual cause of fever,severe hemolyticanemia and thrombocytopenia[J].J Family Med Prim Care,2015,16(4):145-148.